Skip Navigation



QJM Advance Access published online on March 10, 2009
QJM, doi:10.1093/qjmed/hcp025
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
102/5/349    most recent
hcp025v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Boriani, G.
Right arrow Articles by Branzi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boriani, G.
Right arrow Articles by Branzi, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Expenditure and value for money: the challenge of implantable cardioverter defibrillators

G. Boriani, M. Biffi, C. Martignani, I. Diemberger, C. Valzania, M. Bertini and A. Branzi

From the Institute of Cardiology, University of Bologna, Bologna, Italy

Address correspondence to Prof. Giuseppe Boriani, Institute of Cardiology, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy. email: giuseppe.boriani{at}unibo.it


  Abstract

Many technology-driven interventions entail considerable financial cost, raising affordability issues. The implantable cardioverter defibrillator (ICD) is a case of an effective primary prevention intervention with high initial costs that is capable of delivering long-term population benefits. At first glance, such interventions may provoke diffidence, if not active resistance, due to the financial burdens which inevitably accompany their widespread adoption. In this article, we review the available economic tools that can help address the ICD cost issue. We think awareness of such knowledge may facilitate dialogues between physicians, administrators and policymakers, and help foster rational decision-making.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 EuropaceHome page
G. Boriani, M. Biffi, C. Martignani, C. Valzania, I. Diemberger, M. Bertini, G. Domenichini, M. Ziacchi, and A. Branzi
Is cardiac resynchronization therapy cost-effective?
Europace, November 1, 2009; 11(suppl_5): v93 - v97.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.